1. Current and future tools for determination and monitoring of isocitrate dehydrogenase status in gliomas. Issue 6 (December 2018) Authors: Picca, Alberto; Di Stefano, Anna L.; Sanson, Marc Journal: Current opinion in neurology Issue: Volume 31:Issue 6(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Current therapeutic approaches to diffuse grade II and III gliomas. (16th January 2018) Authors: Picca, Alberto; Berzero, Giulia; Sanson, Marc Journal: Therapeutic advances in neurological disorders Issue: Volume 11(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FGFR1 actionable mutations, molecular specificities, and outcome of adult midline gliomas. (5th June 2018) Authors: Picca, Alberto; Berzero, Giulia; Bielle, Franck; Touat, Mehdi; Savatovsky, Julien; Polivka, Marc; Trisolini, Elena; Meunier, Sheida; Schmitt, Yohann; Idbaih, Ahmed; Hoang-Xuan, Khe; Delattre, Jean-Yves; Mokhtari, Karima; Di Stefano, Anna Luisa; Sanson, Marc Journal: Neurology Issue: Volume 90:Number 23(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Interactions between tumor-associated macrophages and tumor cells in glioblastoma: unraveling promising targeted therapies. (2nd September 2018) Authors: Morisse, Mony Chenda; Jouannet, Stéphanie; Dominguez-Villar, Margarita; Sanson, Marc; Idbaih, Ahmed Journal: Expert review of neurotherapeutics Issue: Volume 18:Number 9(2018) Page Start: 729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PATH-16. MOLECULAR PATHOLOGY AND CLINICAL CHARACTERISTICS OF MMR DEFICIENCY (MMRd) IN DIFFUSE GLIOMAS. (5th November 2018) Authors: Touat, Mehdi; Santagata, Sandro; Guillerm, Erell; Bi, Wenya; Beuvon, Frédéric; Mokhtari, Karima; Giry, Marine; Guegan, Justine; Block, Shannon; Carpentier, Alexandre; Delattre, Jean-Yves; Sanson, Marc; Duval, Alex; Beroukhim, Rameen; Bandopadhayay, Pratiti; Reardon, David; Wen, Patrick; Idbaih, A... Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PATH-42. EGFR-AMPLIFIED IDH-WILDTYPE GLIOBLASTOMAS SELDOM TRANSFORM INTO A HYPERMUTATED PHENOTYPE. (5th November 2018) Authors: Draaisma, Kaspar; Chatzipli, Aikaterini; Taphoorn, Martin; Kerkhof, Melissa; Weyerbrock, Astrid; Sanson, Marc; Hoeben, Ann; Lukacova, Slavka; Lombardi, Giuseppe; Hanse, Monique; Fleisscheuer, Ruth; Leenstra, Sieger; Watts, Colin; Gorlia, Thierry; Golfinopoulos, Vassilis; Kros, Johan; McDermott, U... Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The clinical use of IDH1 and IDH2 mutations in gliomas. (2nd December 2018) Authors: Picca, Alberto; Berzero, Giulia; Di Stefano, Anna Luisa; Sanson, Marc Journal: Expert review of molecular diagnostics Issue: Volume 18:Number 12(2018) Page Start: 1041 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Vemurafenib and cobimetinib overcome resistance to vemurafenib in BRAF-mutant ganglioglioma. (11th September 2018) Authors: Touat, Mehdi; Gratieux, Julie; Condette Auliac, Stephanie; Sejean, Karine; Aldea, Sorin; Savatovsky, Julien; Perkins, Géraldine; Blons, Hélène; Ligon, Keith L.; Idbaih, Ahmed; Hollebecque, Antoine; Gimenez-Roqueplo, Anne-Paule; Laurent-Puig, Pierre; Sanson, Marc; Villa, Chiara; Di Stefano, Anna L... Journal: Neurology Issue: Volume 91:Number 11(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗